{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:50:28Z","timestamp":1792799428662,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F30-AI174788"],"award-info":[{"award-number":["F30-AI174788"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 R01AI073755"],"award-info":[{"award-number":["U01 R01AI073755"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI158194"],"award-info":[{"award-number":["R01 AI158194"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32-GM007491"],"award-info":[{"award-number":["T32-GM007491"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32-GM149364"],"award-info":[{"award-number":["T32-GM149364"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.isci.2025.112534","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T11:32:23Z","timestamp":1745926343000},"page":"112534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A two-component cocktail of engineered DIII nanoparticles elicits broadly neutralizing antibody responses against dengue virus in mice"],"prefix":"10.1016","volume":"28","author":[{"given":"Margarette C.","family":"Mariano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen S.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Vergnolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Haskell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamount R.","family":"Evanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Quevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia C.","family":"Frei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa B.","family":"Thackray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4863-0015","authenticated-orcid":false,"given":"Jonathan R.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.112534_bib1","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.112534_bib2","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.08347","article-title":"The global distribution of the arbovirus vectors Aedes aegypti and Ae","volume":"4","author":"Kraemer","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.isci.2025.112534_bib3","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00705-013-1645-3","article-title":"Secondary infection as a risk factor for dengue hemorrhagic fever\/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection","volume":"158","author":"Guzman","year":"2013","journal-title":"Arch. Virol."},{"key":"10.1016\/j.isci.2025.112534_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa3787","article-title":"Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination","volume":"7","author":"Beatty","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2025.112534_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005738","article-title":"Dengue Virus NS1 Disrupts the Endothelial Glycocalyx, Leading to Hyperpermeability","volume":"12","author":"Puerta-Guardo","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.isci.2025.112534_bib6","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.celrep.2019.01.036","article-title":"Flavivirus NS1 Triggers Tissue-Specific Vascular Endothelial Dysfunction Reflecting Disease Tropism","volume":"26","author":"Puerta-Guardo","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2025.112534_bib7","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N. Engl. J. Med. Overseas. Ed."},{"key":"10.1016\/j.isci.2025.112534_bib8","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1016\/S2214-109X(23)00522-3","article-title":"Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4\u00b75-year results from a phase 3, randomised, double-blind, placebo-controlled trial","volume":"12","author":"Tricou","year":"2024","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.isci.2025.112534_bib9","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2254964","article-title":"An open-label, Phase 3 trial of TAK-003, a live attenuated dengue tetravalent vaccine, in healthy US adults: immunogenicity and safety when administered during the second half of a 24-month shelf-life","volume":"19","author":"Patel","year":"2023","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.isci.2025.112534_bib10","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1021\/acscombsci.0c00073","article-title":"Combinatorial Resurfacing of Dengue Envelope Protein Domain III Antigens Selectively Ablates Epitopes Associated with Serotype-Specific or Infection-Enhancing Antibody Responses","volume":"22","author":"Remmel","year":"2020","journal-title":"ACS Comb. Sci."},{"key":"10.1016\/j.isci.2025.112534_bib11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.chembiol.2022.02.004","article-title":"Resurfaced ZIKV EDIII nanoparticle immunogens elicit neutralizing and protective responses in vivo","volume":"29","author":"Georgiev","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.isci.2025.112534_bib12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.virol.2015.08.011","article-title":"Comprehensive mapping of functional epitopes on dengue virus glycoprotein E DIII for binding to broadly neutralizing antibodies 4E11 and 4E5A by phage display","volume":"485","author":"Frei","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.isci.2025.112534_bib13","doi-asserted-by":"crossref","first-page":"e010233-18","DOI":"10.1128\/JVI.01023-18","article-title":"Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice","volume":"92","author":"Frei","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.isci.2025.112534_bib14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","article-title":"Structure of Dengue Virus: Implications for Flavivirus Organization, Maturation, and Fusion","volume":"108","author":"Kuhn","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.112534_bib15","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1073\/pnas.0832193100","article-title":"A ligand-binding pocket in the dengue virus envelope glycoprotein","volume":"100","author":"Modis","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.112534_bib16","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.bbrc.2003.08.053","article-title":"Blocking the dengue virus 2 infections on BHK-21 cells with purified recombinant dengue virus 2 E protein expressed in Escherichia coli","volume":"309","author":"Chiu","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.isci.2025.112534_bib17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1099\/vir.0.037317-0","article-title":"Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan binding","volume":"93","author":"Watterson","year":"2012","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.isci.2025.112534_bib18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.virusres.2008.07.022","article-title":"Characterization of the interaction of domain III of the envelope protein of dengue virus with putative receptors from CHO cells","volume":"137","author":"Huerta","year":"2008","journal-title":"Virus Res."},{"key":"10.1016\/j.isci.2025.112534_bib19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.str.2012.01.001","article-title":"Mechanism of dengue virus broad cross-neutralization by a monoclonal antibody","volume":"20","author":"Cockburn","year":"2012","journal-title":"Structure"},{"key":"10.1016\/j.isci.2025.112534_bib20","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nsmb.1382","article-title":"Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins","volume":"15","author":"Lok","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.isci.2025.112534_bib21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ni.3058","article-title":"A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus","volume":"16","author":"Dejnirattisai","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2025.112534_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature14130","article-title":"Recognition determinants of broadly neutralizing human antibodies against dengue viruses","volume":"520","author":"Rouvinski","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.112534_bib23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nature18938","article-title":"Structural basis of potent Zika-dengue virus antibody cross-neutralization","volume":"536","author":"Barba-Spaeth","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.112534_bib24","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.4049\/jimmunol.1200227","article-title":"Structural analysis of a dengue cross-reactive antibody complexed with envelope domain III reveals the molecular basis of cross-reactivity","volume":"188","author":"Midgley","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2025.112534_bib25","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nm1240","article-title":"Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus","volume":"11","author":"Oliphant","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2025.112534_bib26","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nature03956","article-title":"Structural basis of West Nile virus neutralization by a therapeutic antibody","volume":"437","author":"Nybakken","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.112534_bib27","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cell.2017.04.024","article-title":"Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico","volume":"169","author":"Robbiani","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.112534_bib28","doi-asserted-by":"crossref","first-page":"8826","DOI":"10.1128\/JVI.01314-13","article-title":"Functional Analysis of Antibodies against Dengue Virus Type 4 Reveals Strain-Dependent Epitope Exposure That Impacts Neutralization and Protection","volume":"87","author":"Sukupolvi-Petty","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.isci.2025.112534_bib29","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.cell.2019.01.046","article-title":"Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus","volume":"176","author":"Marcandalli","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.112534_bib30","doi-asserted-by":"crossref","first-page":"11269","DOI":"10.1073\/pnas.1401291111","article-title":"Synthesis of bioactive protein hydrogels by genetically encoded SpyTag-SpyCatcher chemistry","volume":"111","author":"Sun","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.112534_bib31","doi-asserted-by":"crossref","first-page":"E690","DOI":"10.1073\/pnas.1115485109","article-title":"Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin","volume":"109","author":"Zakeri","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.112534_bib32","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2025.112534_bib33","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.immuni.2020.08.001","article-title":"Multifaceted Effects of Antigen Valency on B Cell Response Composition and Differentiation In Vivo","volume":"53","author":"Kato","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2025.112534_bib34","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1006\/jmbi.2000.4435","article-title":"X-ray structure analysis and crystallographic refinement of lumazine synthase from the hyperthermophile Aquifex aeolicus at 1.6 \u00c5 resolution: determinants of thermostability revealed from structural comparisons","volume":"306","author":"Zhang","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.isci.2025.112534_bib35","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1126\/science.1234150","article-title":"Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors","volume":"340","author":"Jardine","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.isci.2025.112534_bib36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jmb.2009.04.078","article-title":"The Crystal Structure of Ferritin from Helicobacter pylori Reveals Unusual Conformational Changes for Iron Uptake","volume":"390","author":"Cho","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.isci.2025.112534_bib37","article-title":"Second career of a biosynthetic enzyme: Lumazine synthase as a virus-like nanoparticle in vaccine development","volume":"27","author":"Ladenstein","year":"2020","journal-title":"Biotechnol. Rep."},{"key":"10.1016\/j.isci.2025.112534_bib38","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1038\/s41467-023-37417-9","article-title":"A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates","volume":"14","author":"Weidenbacher","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.112534_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aba6466","article-title":"A respiratory syncytial virus (RSV) F protein nanoparticle vaccine focuses antibody responses to a conserved neutralization domain","volume":"5","author":"Swanson","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.isci.2025.112534_bib40","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12977-015-0210-4","article-title":"Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity","volume":"12","author":"Sliepen","year":"2015","journal-title":"Retrovirology"},{"key":"10.1016\/j.isci.2025.112534_bib41","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2025.112534_bib42","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.immuni.2019.03.010","article-title":"Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells","volume":"50","author":"Bu","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2025.112534_bib43","article-title":"A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone","volume":"10","author":"Zhang","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2025.112534_bib44","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1126\/science.aat9120","article-title":"Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers","volume":"363","author":"Tokatlian","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.isci.2025.112534_bib45","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3390\/vaccines9060651","article-title":"Development of a Modular Vaccine Platform for Multimeric Antigen Display Using an Orthobunyavirus Model","volume":"9","author":"Aebischer","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.isci.2025.112534_bib46","doi-asserted-by":"crossref","first-page":"e371","DOI":"10.1038\/am.2016.128","article-title":"Engineering protein nanocages as carriers for biomedical applications","volume":"9","author":"Bhaskar","year":"2017","journal-title":"NPG Asia Mater."},{"key":"10.1016\/j.isci.2025.112534_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01093","article-title":"Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus Nanoparticles","volume":"9","author":"Kim","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.112534_bib48","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1038\/s41467-021-22867-w","article-title":"Single-component multilayered self-assembling nanoparticles presenting rationally designed glycoprotein trimers as Ebola virus vaccines","volume":"12","author":"He","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.112534_bib49","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41541-021-00364-x","article-title":"Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers","volume":"6","author":"Sliepen","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.isci.2025.112534_bib50","article-title":"Design of universal Ebola virus vaccine candidates via immunofocusing","volume":"121","author":"Xu","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.112534_bib51","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1021\/acs.biochem.2c00241","article-title":"Simplified Purification of Glycoprotein-Modified Ferritin Nanoparticles for Vaccine Development","volume":"62","author":"Weidenbacher","year":"2023","journal-title":"Biochemistry"},{"key":"10.1016\/j.isci.2025.112534_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010573","article-title":"A Powassan virus domain III nanoparticle immunogen elicits neutralizing and protective antibodies in mice","volume":"18","author":"Malonis","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.isci.2025.112534_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208310","article-title":"The adjuvant AlhydroGel elicits higher antibody titres than AddaVax when combined with HIV-1 subtype C gp140 from CAP256","volume":"13","author":"van Diepen","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.112534_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123836","article-title":"Comparative study of acetalated-dextran microparticle fabrication methods for a clinically translatable subunit-based influenza vaccine","volume":"652","author":"Pena","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.isci.2025.112534_bib55","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.vaccine.2023.11.048","article-title":"Production, purification and immunogenicity of Gag virus-like particles carrying SARS-CoV-2 components","volume":"42","author":"Gashti","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2025.112534_bib56","article-title":"Effects of Adjuvants on the Immunogenicity and Efficacy of a Zika Virus Envelope Domain III Subunit Vaccine","volume":"7","author":"Wang","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.isci.2025.112534_bib57","doi-asserted-by":"crossref","first-page":"E1555","DOI":"10.1073\/pnas.1303645110","article-title":"Redesign of a cross-reactive antibody to dengue virus with broad-spectrum activity and increased in vivo potency","volume":"110","author":"Tharakaraman","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.112534_bib58","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.cell.2015.06.057","article-title":"Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope","volume":"162","author":"Robinson","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.112534_bib59","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.chom.2021.09.006","article-title":"Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunity","volume":"29","author":"Chen","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.isci.2025.112534_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/srep19193","article-title":"Bispecific Antibody Affords Complete Post-Exposure Protection of Mice from Both Ebola (Zaire) and Sudan Viruses","volume":"6","author":"Frei","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2025.112534_bib61","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1126\/science.7529940","article-title":"A hot spot of binding energy in a hormone-receptor interface","volume":"267","author":"Clackson","year":"1995","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.isci.2025.112534_bib62","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.aac7263","article-title":"A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"Impagliazzo","year":"2015","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.isci.2025.112534_bib63","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.chom.2019.04.003","article-title":"Influenza Antigen Engineering Focuses Immune Responses to a Subdominant but Broadly Protective Viral Epitope","volume":"25","author":"Bajic","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.isci.2025.112534_bib64","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15411","article-title":"Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope","volume":"8","author":"Rouvinski","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.112534_bib65","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1038\/s41467-019-12677-6","article-title":"Oligomeric state of the ZIKV E protein defines protective immune responses","volume":"10","author":"Metz","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.112534_bib66","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41598-017-01097-5","article-title":"Temperature-dependent folding allows stable dimerization of secretory and virus-associated E proteins of Dengue and Zika viruses in mammalian cells","volume":"7","author":"Slon Campos","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2025.112534_bib67","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/s41590-019-0477-z","article-title":"A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection","volume":"20","author":"Slon-Campos","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2025.112534_bib68","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/cid\/cit684","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.isci.2025.112534_bib69","first-page":"CD001261","article-title":"Vaccines for preventing typhoid fever","volume":"5","author":"Milligan","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.isci.2025.112534_bib70","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.vaccine.2017.07.066","article-title":"Measles vaccines: WHO position paper, April 2017 \u2013 Recommendations","volume":"37","author":"World Health","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2025.112534_bib71","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.abf6840","article-title":"Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice","volume":"371","author":"Cohen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.isci.2025.112534_bib72","doi-asserted-by":"crossref","DOI":"10.1126\/science.abq0839","article-title":"Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models","volume":"377","author":"Cohen","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.isci.2025.112534_bib76","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jmb.2013.10.021","article-title":"Structural analysis and optimization of the covalent association between SpyCatcher and a peptide Tag","volume":"426","author":"Li","year":"2014","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.isci.2025.112534_bib73","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jim.2007.01.008","article-title":"Antibody internalization studied using a novel IgG binding toxin fusion","volume":"321","author":"Mazor","year":"2007","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.isci.2025.112534_bib74","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/bs.mie.2016.05.005","article-title":"Protein and Antibody Engineering by Phage Display","volume":"580","author":"Frei","year":"2016","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.isci.2025.112534_bib75","doi-asserted-by":"crossref","first-page":"10630","DOI":"10.1128\/JVI.01190-10","article-title":"Genotype-Specific Neutralization and Protection by Antibodies against Dengue Virus Type 3","volume":"84","author":"Brien","year":"2010","journal-title":"J. Virol."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225007953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225007953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T02:51:58Z","timestamp":1768963918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225007953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":76,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2589004225007953"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.112534","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A two-component cocktail of engineered DIII nanoparticles elicits broadly neutralizing antibody responses against dengue virus in mice","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.112534","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112534"}}